GH Research
$15.82
53
+$0.16+1.02% Monday 21:00
Statistics
Day High
16.33
Day Low
15.42
52W High
20.5
52W Low
7.98
Volume
163,446
Avg. Volume
435,862
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
26FebExpected
Expected EPS
-0.266667
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-42.92MNet Income
Analyst Ratings
$35.75Average Price Target
The highest estimate is 40.00.
From 4 ratings within the last 6 months. This is not an investment recommendation.
From 4 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow GHRS. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Compass Pathways
CMPS
Mkt Cap606.35M
Mind Medicine Inc
MNMD
Mkt Cap1.38B
AtaiBeckley
ATAI
Mkt Cap1.56B
Cybin Inc
CYBN
Mkt Cap200.49M
Nuveen Municipal Income
NUMI
Mkt Cap0
Revive Therapeutics
RVVTF
Mkt Cap4.68M
Johnson & Johnson
JNJ
Mkt Cap455.04B
About
GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH001, an inhalable 5-MeO-DMT product candidate that has completed two Phase 1 clinical trials and Phase 1/2 clinical trial in patients with TRD. The company also develops GH002, an injectable 5-MeO-DMT product candidate; and GH003, an intranasal 5-MeO-DMT product candidate, which are in preclinical development trials with a focus on psychiatric and neurological disorders. GH Research PLC was incorporated in 2018 and is based in Dublin, Ireland.
Show more...
CEO
Mr. Florian Schonharting M.Sc. (Econ)
Employees
50
Country
IE
ISIN
IE000GID8VI0
Listings
0 Comments
Share your thoughts
FAQ
What is GH Research stock price today?▼
The current price of GHRS is $15.82 USD — it has increased by +1.02% in the past 24 hours. Watch GH Research stock price performance more closely on the chart.
What is GH Research stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange GH Research stocks are traded under the ticker GHRS.
Is GH Research stock price growing?▼
GHRS stock has fallen by -2.41% compared to the previous week, the month change is a +19.49% rise, over the last year GH Research has showed a -12.06% decrease.
When is the next GH Research earnings date?▼
GH Research is going to release the next earnings report on February 26, 2026.
What were GH Research earnings last quarter?▼
GHRS earnings for the last quarter are -0.23 USD per share, whereas the estimation was -0.24 USD resulting in a +2.82% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is GH Research revenue for the last year?▼
GH Research revenue for the last year amounts to 0 USD.
What is GH Research net income for the last year?▼
GHRS net income for the last year is -42.92M USD.
How many employees does GH Research have?▼
As of February 03, 2026, the company has 50 employees.
In which sector is GH Research located?▼
GH Research operates in the Health Care sector.
When did GH Research complete a stock split?▼
GH Research has not had any recent stock splits.
Where is GH Research headquartered?▼
GH Research is headquartered in Dublin, IE.